Last Updated: November 8, 2026

MYDRIACYL Drug Patent Profile

« Back to Dashboard


Which patents cover Mydriacyl, and when can generic versions of Mydriacyl launch?

Mydriacyl is a drug marketed by Alcon, Alcon Labs Inc, and Sandoz. and is included in three NDAs.

The generic ingredient in MYDRIACYL is tropicamide. There is one drug master file entry for this compound. Five suppliers are listed for this compound. Additional details are available on the tropicamide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Mydriacyl

A generic version of MYDRIACYL was approved as tropicamide by BAUSCH AND LOMB on July 27th, 1994.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for MYDRIACYL?
  • What are the global sales for MYDRIACYL?
  • What is Average Wholesale Price for MYDRIACYL?
Recent Clinical Trials for MYDRIACYL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Wake Forest University Health SciencesPhase 4
University of California, San FranciscoPhase 4
Winston Chamberlain, MD, PhDPhase 4

See all MYDRIACYL clinical trials

Pharmacology for MYDRIACYL
Drug ClassAnticholinergic
Mechanism of ActionCholinergic Antagonists

US Patents and Regulatory Information for MYDRIACYL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon MYDRIACYL tropicamide SOLUTION/DROPS;OPHTHALMIC 012111-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Sandoz MYDRIACYL tropicamide SOLUTION/DROPS;OPHTHALMIC 084305-001 Approved Prior to Jan 1, 1982 AT RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Alcon MYDRIACYL tropicamide SOLUTION/DROPS;OPHTHALMIC 012111-004 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Alcon Labs Inc MYDRIACYL tropicamide SOLUTION/DROPS;OPHTHALMIC 084306-001 Approved Prior to Jan 1, 1982 AT RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.